MYD88 and myocardial infarction: MyD88 mediates the TLR4/NF-κB inflammatory pathway to prevent isoproterenol- (ISO-) induced AMI, and inhibiting MyD88 expression prevents pathological left ventricular remodeling and alleviates myocardial infarction injury [62, 63].